Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Oct;40(10):2227-2234.
doi: 10.1007/s10096-021-04213-6. Epub 2021 Mar 17.

Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit

Affiliations
Observational Study

Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit

Naouale Maataoui et al. Eur J Clin Microbiol Infect Dis. 2021 Oct.

Abstract

Because the diagnosis of co/superinfection in COVID-19 patients is challenging, empirical antibiotic therapy is frequently initiated until microbiological analysis results. We evaluated the performance and the impact of the BioFire® FilmArray® Pneumonia plus Panel on 112 respiratory samples from 67 COVID-19 ICU patients suspected of co/superinfections. Globally, the sensitivity and specificity of the test were 89.3% and 99.1%, respectively. Positive tests led to antibiotic initiation or adaptation in 15% of episodes and de-escalation in 4%. When negative, 28% of episodes remained antibiotic-free (14% no initiation, 14% withdrawal). Rapid multiplex PCRs can help to improve antibiotic stewardship by administering appropriate antibiotics earlier and avoiding unnecessary prescriptions.

Keywords: Antibiotic stewardship; COVID-19; Coinfection; Multiplex PCR; Superinfection.

PubMed Disclaimer

Conflict of interest statement

ERu received funds from bioMérieux and speaking fees from Mobidiag. JFT received lecture fees from bioMérieux and participates, outside of the submitted work, on the advisory boards of MSD, Pfizer, Bayer, Nabriva, Gilead, BD, 3M, Paratek. LA received speaking fees from bioMérieux.

References

    1. Bouadma L, Lescure F-X, Lucet J-C, Yazdanpanah Y, Timsit J-F. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020 26;1–4. 10.1007/s00134-020-05967-x - PMC - PubMed
    1. Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, et al. A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Crit Care Med. 2019;47:345–352. doi: 10.1097/CCM.0000000000003553. - DOI - PubMed
    1. Cox MJ, Loman N, Bogaert D, O’Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020;1:e11. doi: 10.1016/S2666-5247(20)30009-4. - DOI - PMC - PubMed
    1. Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. 2020;75:1730–1741. doi: 10.1111/all.14238. - DOI - PubMed
    1. Rawson TM, Ming D, Ahmad R, Moore LSP, Holmes AH (2020) Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol [Internet]. 10.1038/s41579-020-0395-y - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources